Acadia Pharmaceuticals buy Mizuho
Start price
23.02.26
/
50%
€20.85
Target price
23.02.27
€29.59
Performance (%)
4.22%
Price
27.07.26
€22.34
Summary
This prediction is currently active. The BUY prediction by Mizuho shows slight gains of 4.22%. This prediction currently runs until 23.02.27. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 1.684% | 1.684% |
| iShares Core DAX® | 2.992% | 3.220% |
| iShares Nasdaq 100 | -1.584% | -3.172% |
| iShares Nikkei 225® | -2.254% | -9.924% |
| iShares S&P 500 | -0.009% | 1.641% |
Comments by Mizuho for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $35.00 price target on the stock, up previously from $29.00.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Mizuho for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€36.02
28.02.25
28.02.25
-19.75%
01.03.25
01.03.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
29.12.23
29.12.23
€36.19
29.12.24
29.12.24
-42.54%
30.12.24
30.12.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.40
06.11.23
06.11.23
€32.59
06.11.24
06.11.24
-31.70%
07.11.24
07.11.24

